Pathology International最新文献_第5页

Cystic primary squamous cell carcinoma of the thyroid. 甲状腺囊性原发鳞状细胞癌。

IF 2.5 4区医学

Pathology International Pub Date : 2024-05-01 Epub Date: 2024-03-28 DOI: 10.1111/pin.13422

Sakurako Harada-Kagitani, Yusuke Kouchi, Yoshiki Shinomiya, Takuto Hiramoto, Tomoyuki Arai, Toyoyuki Hanazawa, Kiyotaka Onodera, Kaito Nakama, Takanori Aihara, Masayuki Ota, Jun-Ichiro Ikeda, Takashi Kishimoto

引用次数: 0

Evaluation of pancreatic cancer specimens for comprehensive genomic profiling. 评估胰腺癌标本以进行全面基因组分析。

IF 2.2 4区医学

Pathology International Pub Date : 2024-05-01 Epub Date: 2024-03-13 DOI: 10.1111/pin.13416

Kota Washimi, Yukihiko Hiroshima, Shinya Sato, Makoto Ueno, Satoshi Kobayashi, Naoto Yamamoto, Chie Hasegawa, Emi Yoshioka, Kyoko Ono, Yoichiro Okubo, Tomoyuki Yokose, Yohei Miyagi

{"title":"Evaluation of pancreatic cancer specimens for comprehensive genomic profiling.","authors":"Kota Washimi, Yukihiko Hiroshima, Shinya Sato, Makoto Ueno, Satoshi Kobayashi, Naoto Yamamoto, Chie Hasegawa, Emi Yoshioka, Kyoko Ono, Yoichiro Okubo, Tomoyuki Yokose, Yohei Miyagi","doi":"10.1111/pin.13416","DOIUrl":"10.1111/pin.13416","url":null,"abstract":"Inadequate specimen quality or quantity hinders comprehensive genomic profiling in identifying actionable mutations and guiding treatment strategies. We investigated the optimal conditions for pancreatic cancer specimen selection for comprehensive genomic profiling. We retrospectively analyzed 213 pancreatic cancer cases ordered for comprehensive genomic profiling and compared results from pancreatic biopsy, liver biopsy of pancreatic cancer metastases, pancreatectomy, liquid, and nonliver metastatic organ specimens. We examined preanalytical conditions, including cellularity (tumor cell count/size). The successfully tested cases were those that underwent comprehensive genomic profiling tests without any issues. The successfully tested case ratio was 72.8%. Pancreatic biopsy had the highest successfully tested case ratio (87%), with a high tumor cell percentage, despite the small number of cells (median, 3425). Pancreatic biopsy, liver biopsy of pancreatic cancer metastases, and non-liver metastatic organ had higher successfully tested case ratios than that for pancreatectomy. Liver biopsy of pancreatic cancer metastases and pancreatectomy cases with tumor size (mm2) × tumor ratio (%) > 150 and >3000, respectively, had high successfully tested case ratios. The success of comprehensive genomic profiling is significantly influenced by the tumor cell ratio, and pancreatic biopsy is a potentially suitable specimen for comprehensive genomic profiling.","PeriodicalId":19806,"journal":{"name":"Pathology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Low-grade carcinoma with acinic cell carcinoma-like features of the parotid gland with CRTC3::IQGAP1 fusion. 伴有 CRTC3::IQGAP1 融合的腮腺低分化癌，具有尖细胞癌样特征。

IF 2.2 4区医学

Pathology International Pub Date : 2024-05-01 Epub Date: 2024-04-02 DOI: 10.1111/pin.13423

Masami Iwamoto, Taisuke Mori, Eijitsu Ryo, Shoko Handa, Yuuki Nishimura, Masato Nagaoka, Masayuki Shimoda

引用次数: 0

Clinicopathological importance of Bcl-2 and p53 in postmenopausal triple-negative breast carcinoma and association with age. 绝经后三阴性乳腺癌中 Bcl-2 和 p53 的临床病理学重要性以及与年龄的关系。

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-24 DOI: 10.1111/pin.13429

Kei Ito, N. Honma, Hideaki Ogata, Akimitsu Yamada, Mika Miyashita, Tomio Arai, E. Sasaki, Kazutoshi Shibuya, Tetuo Mikami, Masataka Sawaki

{"title":"Clinicopathological importance of Bcl-2 and p53 in postmenopausal triple-negative breast carcinoma and association with age.","authors":"Kei Ito, N. Honma, Hideaki Ogata, Akimitsu Yamada, Mika Miyashita, Tomio Arai, E. Sasaki, Kazutoshi Shibuya, Tetuo Mikami, Masataka Sawaki","doi":"10.1111/pin.13429","DOIUrl":"https://doi.org/10.1111/pin.13429","url":null,"abstract":"Appropriate biomarkers are required to predict the clinical outcome of triple-negative breast cancer (TNBC). In this study, we focused on the clinical importance of two representative tumor-associated proteins, Bcl-2 and p53. Bcl-2 expression is usually related to estrogen receptor expression and a favorable outcome in breast cancer. TNBC has been reported to show a high frequency of p53 positivity suggesting TP53 mutations. The expressions of Bcl-2 and p53 were immunohistochemically examined in TNBC involving two age groups of postmenopausal women (≥75 y/o, n = 75; 55-64 y/o, n = 47), who underwent surgery without neoadjuvant therapy. We examined their associations with each other, or with clinicopathological factors including the outcome. Bcl-2 expression was inversely correlated with androgen receptor, apocrine morphology, and p53 expressions, and was an independent predictor of a poor outcome in total or in younger women. p53 positivity was associated with a more favorable outcome than p53 negativity in the younger group. In combined analyzes, none of the twenty Bcl-2-negative/p53-positive cases in the younger group exhibited recurrence, resulting in the independent favorable predictive value of Bcl-2-negative/p53-positive. The anti-apoptotic nature of Bcl-2 may be apparent in TNBC. The excellent outcome of Bcl-2-negative/p53-positive cases in the younger group warrants further combined investigation of Bcl-2/p53 in TNBC.","PeriodicalId":19806,"journal":{"name":"Pathology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140661601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Composite ALK-negative anaplastic large cell lymphoma and follicular lymphoma involving jejunum and mesenteric lymph nodes. ALK阴性的非典型大细胞淋巴瘤和滤泡性淋巴瘤复合体，累及空肠和肠系膜淋巴结。

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-24 DOI: 10.1111/pin.13433

Qiongzhi Yang, Tianming Zhang, Na Fang, Wenjia Sun

引用次数: 0

Retinal gliosis with osseous metaplasia in an infant. 婴儿视网膜胶质细胞病变并伴有骨化。

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-23 DOI: 10.1111/pin.13431

Daichi Morii, T. Matsui, Taisuke Mori, Y. Yatabe, Eiichi Morii

引用次数: 0

Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma. 胃腺癌的分子分类和瘤内异质性。

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-23 DOI: 10.1111/pin.13427

Takeshi Kuwata

引用次数: 0

The first lichen planus case coexisting bronchiolitis obliterans without malignant tumors. 首例扁平苔藓与无恶性肿瘤的闭塞性支气管炎并存的病例。

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-23 DOI: 10.1111/pin.13432

T. Nikaido, Y. Tanino, Yuki Sato, R. Togawa, N. Watanabe, Xintao Wang, Naoko Fukuhara, Rina Harigane, Koshi Saito, Kentaro Kazama, Ryuki Yamada, Riko Sato, H. Tomita, Mami Rikimaru, Yasuhito Suzuki, H. Minemura, J. Saito, Kenya Kanazawa, Toshiyuki Yamamoto, Yuko Hashimoto, Akira Hebisawa, Yoko Shibata

引用次数: 0

Predominant CD8+ cell infiltration and low accumulation of regulatory T cells in immune checkpoint inhibitor‐induced tubulointerstitial nephritis 在免疫检查点抑制剂诱导的肾小管间质性肾炎中，CD8+细胞浸润占主导地位，而调节性T细胞积累较少

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-18 DOI: 10.1111/pin.13428

Kenta Tominaga, Etsuko Toda, Kazuhiro Takeuchi, Shoichiro Takakuma, Emi Sakamoto, Hideaki Kuno, Yusuke Kajimoto, Yasuhiro Terasaki, Shinobu Kunugi, Akiko Mii, Yukinao Sakai, Mika Terasaki, Akira Shimizu

{"title":"Predominant CD8+ cell infiltration and low accumulation of regulatory T cells in immune checkpoint inhibitor‐induced tubulointerstitial nephritis","authors":"Kenta Tominaga, Etsuko Toda, Kazuhiro Takeuchi, Shoichiro Takakuma, Emi Sakamoto, Hideaki Kuno, Yusuke Kajimoto, Yasuhiro Terasaki, Shinobu Kunugi, Akiko Mii, Yukinao Sakai, Mika Terasaki, Akira Shimizu","doi":"10.1111/pin.13428","DOIUrl":"https://doi.org/10.1111/pin.13428","url":null,"abstract":"Immune checkpoint inhibitors (ICIs) can provide survival benefits to cancer patients; however, they sometimes result in the development of renal immune‐related adverse events (irAEs). Tubulointerstitial nephritis (TIN) is the most representative pathological feature of renal irAEs. However, the clinicopathological entity and underlying pathogenesis of ICI‐induced TIN are unclear. Therefore, we compared the clinical and histological features of this condition with those of non‐ICI drug‐induced TIN. Age and C‐reactive protein levels were significantly higher in ICI‐induced TIN, but there were no significant differences in renal function. Immunophenotyping of ICI‐induced TIN showed massive T cell and macrophage infiltration with fewer B cells, plasma cells, neutrophils, and eosinophils. Compared with those in non‐ICI drug‐induced TIN, CD4+ cell numbers were significantly lower in ICI‐induced TIN but CD8+ cell numbers were not significantly different. However, CD8/CD3 and CD8/CD4 ratios were higher in ICI‐induced TIN. Moreover, CD25+ and FOXP3+ cells, namely regulatory T cells, were less abundant in ICI‐induced TIN. In conclusion, T cell, B cell, plasma cell, neutrophil, and eosinophil numbers proved useful for differentiating ICI‐induced and non‐ICI drug‐induced TIN. Furthermore, the predominant distribution of CD8+ cells and low accumulation of regulatory T cells might be associated with ICI‐induced TIN development.","PeriodicalId":19806,"journal":{"name":"Pathology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140625039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling 小细胞肺癌的分子病理学：受 ASCL1 和 Notch 信号调控的神经内分泌分化研究综述

IF 2.2 4区医学

Pathology International Pub Date : 2024-04-12 DOI: 10.1111/pin.13426

Takaaki Ito

{"title":"Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling","authors":"Takaaki Ito","doi":"10.1111/pin.13426","DOIUrl":"https://doi.org/10.1111/pin.13426","url":null,"abstract":"Pulmonary neuroendocrine (NE) cells are rare airway epithelial cells. The balance between Achaete‐scute complex homolog 1 (ASCL1) and hairy and enhancer of split 1, one of the target molecules of the Notch signaling pathway, is crucial for NE differentiation. Small cell lung cancer (SCLC) is a highly aggressive lung tumor, characterized by rapid cell proliferation, a high metastatic potential, and the acquisition of resistance to treatment. The subtypes of SCLC are defined by the expression status of NE cell‐lineage transcription factors, such as ASCL1, which roles are supported by SRY‐box 2, insulinoma‐associated protein 1, NK2 homeobox 1, and wingless‐related integration site signaling. This network reinforces NE differentiation and may induce the characteristic morphology and chemosensitivity of SCLC. Notch signaling mediates cell‐fate decisions, resulting in an NE to non‐NE fate switch. The suppression of NE differentiation may change the histological type of SCLC to a non‐SCLC morphology. In SCLC with NE differentiation, Notch signaling is typically inactive and genetically or epigenetically regulated. However, Notch signaling may be activated after chemotherapy, and, in concert with Yes‐associated protein signaling and RE1‐silencing transcription factor, suppresses NE differentiation, producing intratumor heterogeneity and chemoresistance. Accumulated information on the molecular mechanisms of SCLC will contribute to further advances in the control of this recalcitrant cancer.","PeriodicalId":19806,"journal":{"name":"Pathology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140583656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0